About this trial
This is a multicentre prospective international observational study. This study aims to introduce a novel multidimensional approach to precision imaging, enabling the identification and stratification of high-risk patients who can potentially benefit from early treatments to halt the progression of Crohn's disease (CD). The investigators will develop a novel endoscopic assessment system using endoscopic enhanced imaging (EEI) to evaluate early post-surgical changes and predict post-operative CD recurrence (POCr). By integrating with immune marker profiling, clinical data, and AI assessment of EEI and histology, the investigators further plan to improve risk stratification and reduce interobserver variability.
Eligibility criteria
Qualifiers
Patients aged between 18 years and 75 years.
Established diagnosis of CD at least six months prior to study.
Patients who have undergone intestinal resection within 3 months before study entry or have surgery planned.
Disqualifiers
Inability to provide consent.
Presence of serious co-morbidities (clinical contraindication).
Presence of ostomy.
Pregnancy or breastfeeding.
Trial design
Treatments tested in this trial
- Colonoscopy
- Intestinal biopsies
- Confocal laser endomicroscopy
- Intestinal ultrasound
- Stool
- Blood
- Saliva
- Clinical follow-up
Treatment groups
Sponsors and collaborators
University College Cork
Lead sponsor
The Leona M. and Harry B. Helmsley Charitable Trust
Collaborator